NO-13065 / Otsuka - LARVOL DELTA

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects (clinicaltrials.gov) - P1 | N=84 | Completed | Sponsor: Otsuka Pharmaceutical Factory, Inc. | Active, not recruiting ➔ Completed

Trial completion • Genetic Disorders • Obesity

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Food Effect of NO-13065 in Healthy and Obese Adult Subjects (clinicaltrials.gov) - P1 | N=84 | Active, not recruiting | Sponsor: Otsuka Pharmaceutical Factory, Inc. | Recruiting ➔ Active, not recruiting | Trial completion date: May 2022 ➔ Sep 2022

Enrollment closed • Trial completion date • Genetic Disorders • Obesity